Regulation of signal transduction pathways in colorectal cancer: Implications for therapeutic resistance

9Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Resistance to anti-cancer treatments is a critical and widespread health issue that has brought serious impacts on lives, the economy and public policies. Mounting research has suggested that a selected spectrum of patients with advanced colorectal cancer (CRC) tend to respond poorly to both chemotherapeutic and targeted therapeutic regimens. Drug resistance in tumours can occur in an intrinsic or acquired manner, rendering cancer cells insensitive to the treatment of anti-cancer therapies. Multiple factors have been associated with drug resistance. The most well-established factors are the emergence of cancer stem cell-like properties and overexpression of ABC transporters that mediate drug efflux. Besides, there is emerging evidence that signalling pathways that modulate cell survival and drug metabolism play major roles in the maintenance of multidrug resistance in CRC. This article reviews drug resistance in CRC as a result of alterations in the MAPK, PI3K/PKB, Wnt/β-catenin and Notch pathways.

Cite

CITATION STYLE

APA

Yeoh, Y., Low, T. Y., Abu, N., & Lee, P. Y. (2021). Regulation of signal transduction pathways in colorectal cancer: Implications for therapeutic resistance. PeerJ. PeerJ Inc. https://doi.org/10.7717/peerj.12338

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free